View the source FDA Guidance: Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency - Guidance for Industry (PDF)
According to the guidance:
"FDA is issuing this guidance to help drug and biological product manufacturers during the COVID-19 public health emergency plan and prioritize current good manufacturing practice (CGMP) activities as they transition from operations impacted by the public health emergency to normal manufacturing operations. This guidance describes how to evaluate and prioritize the remediation of CGMP activities that were necessarily delayed, reduced, or otherwise modified during the public health emergency in order to maintain production and the drug supply."
Return to SkillsPlus International Info Blog - HomeSkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!
You might also like FDA GMP QSR cGMP Training: FDA GMP QSR cGMP Training - online training courses by SkillsPlus International Inc. #FDA #cGMP #GMP #QSR #training
ReplyDeleteFDA GMP QSR cGMP Training: FDA GMP QSR cGMP Training - online training courses by SkillsPlus International Inc. #FDA #cGMP #GMP #QSR #training
ReplyDelete